Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Jul 27, 2026; 18(7): 120222
Published online Jul 27, 2026. doi: 10.4240/wjgs.v18.i7.120222
Published online Jul 27, 2026. doi: 10.4240/wjgs.v18.i7.120222
Table 1 Baseline demographic and clinical characteristics of patients before and after propensity score matching, n (%)/mean ± SD
| Characteristic | Pre-matched cohort | Post-matched cohort (n = 125 pairs) | ||||||||
| Watson-FTS | Routine care | Test statistic | P value | SMD | Watson-FTS | Routine care | Test statistic | P value | SMD | |
| Demographics | ||||||||||
| Age, years | 62.1 ± 10.8 | 64.5 ± 11.4 | 1.91 | 0.057 | 0.22 | 63.2 ± 10.5 | 63.5 ± 10.9 | 0.22 | 0.825 | 0.03 |
| Male gender | 96 (58.2) | 85 (57.8) | 0.01 | 0.948 | 0.01 | 72 (57.6) | 71 (56.8) | 0.02 | 0.898 | 0.02 |
| BMI, kg/m2 | 23.6 ± 3.4 | 23.1 ± 3.7 | 1.24 | 0.216 | 0.14 | 23.4 ± 3.2 | 23.3 ± 3.5 | 0.24 | 0.814 | 0.03 |
| Education (> high school) | 91 (55.2) | 59 (40.1) | 6.99 | 0.008 | 0.31 | 58 (46.4) | 60 (48.0) | 0.06 | 0.799 | 0.03 |
| Clinical status | ||||||||||
| ASA class III | 45 (27.3) | 38 (25.9) | 0.08 | 0.776 | 0.03 | 34 (27.2) | 33 (26.4) | 0.02 | 0.887 | 0.02 |
| NRS 2002 score | 2.6 ± 0.9 | 2.5 ± 1.1 | 0.88 | 0.38 | 0.1 | 2.5 ± 0.8 | 2.5 ± 0.9 | 0 | 1 | 0 |
| CCI score | 2.4 ± 1.5 | 2.6 ± 1.7 | 1.1 | 0.272 | 0.12 | 2.5 ± 1.4 | 2.5 ± 1.5 | 0 | 1 | 0 |
| Smoking (current/former) | 64 (38.8) | 61 (41.5) | 0.24 | 0.624 | 0.06 | 49 (39.2) | 51 (40.8) | 0.07 | 0.796 | 0.03 |
| Neoadjuvant therapy | 35 (21.2) | 28 (19.0) | 0.24 | 0.627 | 0.05 | 25 (20.0) | 26 (20.8) | 0.02 | 0.879 | 0.02 |
| Psychological status | ||||||||||
| HADS-anxiety | 9.6 ± 3.1 | 7.9 ± 3.4 | 4.61 | < 0.001 | 0.52 | 8.8 ± 2.9 | 8.9 ± 3.2 | 0.26 | 0.795 | 0.03 |
| HADS-depression | 8.9 ± 3.3 | 7.4 ± 3.2 | 4.07 | < 0.001 | 0.46 | 8.2 ± 3.0 | 8.3 ± 2.8 | 0.27 | 0.785 | 0.03 |
| Surgical/oncological | ||||||||||
| Laparoscopic approach | 140 (84.8) | 101 (68.7) | 11.52 | 0.001 | 0.4 | 95 (76.0) | 94 (75.2) | 0.02 | 0.885 | 0.02 |
| AJCC TNM stage III | 88 (53.3) | 76 (51.7) | 0.08 | 0.775 | 0.03 | 66 (52.8) | 65 (52.0) | 0.02 | 0.898 | 0.02 |
| Tumor location (rectum) | 102 (61.8) | 94 (63.9) | 0.15 | 0.697 | 0.04 | 78 (62.4) | 79 (63.2) | 0.02 | 0.894 | 0.02 |
| Permanent stoma | 65 (39.4) | 62 (42.2) | 0.25 | 0.617 | 0.06 | 50 (40.0) | 49 (39.2) | 0.02 | 0.892 | 0.02 |
| Preop albumin, g/L | 36.4 ± 4.5 | 36.9 ± 4.8 | 0.95 | 0.343 | 0.11 | 36.6 ± 4.2 | 36.7 ± 4.4 | 0.18 | 0.854 | 0.02 |
| Preop prealbumin, mg/L | 224 ± 51 | 219 ± 55 | 0.83 | 0.407 | 0.09 | 221 ± 48 | 223 ± 50 | 0.32 | 0.748 | 0.04 |
Table 2 Comparison of primary outcomes in the matched cohort (n = 250), n (%)/mean ± SD
| Outcome | Watson-FTS | Routine care | Unadjusted difference | Adjusted effect (95%CI)1 | P value |
| First flatus time (hours) | 52.4 ± 10.8 | 68.1 ± 13.5 | -15.7 | β: -15.2 (-18.4 to -12.0) | < 0.001 |
| Overall complications | 19 (15.2) | 38 (30.4) | -15.20 | aOR: 0.39 (0.21-0.72) | 0.003 |
| Clavien-Dindo severity | |||||
| Grade I-II | 15 (12.0) | 30 (24.0) | -12.00 | aOR: 0.43 (0.22-0.85) | 0.015 |
| Grade ≥ III | 4 (3.2) | 8 (6.4) | -3.20 | aOR: 0.48 (0.14-1.66) | 0.246 |
| Stoma-related events | 6 (4.8) | 16 (12.8) | -8.00 | aOR: 0.34 (0.13-0.89) | 0.024 |
Table 3 Comparison of secondary outcomes in the matched cohort (n = 250), n (%)/mean ± SD
| Outcome dimension | Watson-FTS (n = 125) | Routine care (n = 125) | Unadjusted difference | Adjusted effect (95%CI)1 | P value |
| Physiological and functional | |||||
| First ambulation time (hours) | 26.4 ± 6.2 | 38.9 ± 8.5 | -12.5 | β: -12.1 (-13.8 to -10.4) | < 0.001 |
| Postoperative stay (days)2, median (IQR) | 7.0 (6.0, 8.0) | 9.0 (7.5, 11.0) | -2.0 | β: -1.8 (-2.3 to -1.3) | < 0.001 |
| Discharge KPS score | 84.5 ± 5.2 | 78.2 ± 6.1 | +6.3 | β: +5.9 (4.6-7.2) | < 0.001 |
| Humanistic process quality | |||||
| Teach-back completion | 115 (92.0) | 81 (64.8) | +27.2 | aOR: 5.82 (2.76-12.28) | < 0.001 |
| Individualized plan rate | 111 (88.8) | 65 (52.0) | +36.8 | aOR: 7.14 (3.58-14.24) | < 0.001 |
| Self-efficacy milestone3 | 102 (81.6) | 71 (56.8) | +24.8 | aOR: 3.25 (1.84-5.74) | < 0.001 |
Table 4 Generalized estimating equation model results for nutritional trajectories and protocol adherence (n = 250)
| Model parameter | Prealbumin (mg/L) | P value | FTS adherence (yes) | P value |
| Intercept | 222.8 (215.4-230.2) | < 0.001 | 0.82 (0.54-1.25) | 0.358 |
| Group (Watson-FTS vs control) | 5.48 (2.12-8.84) | 0.001 | 2.15 (1.42-3.26) | < 0.001 |
| Time (categorical reference: T1) | ||||
| T2 (day 3 for nutrition/adherence) | 17.6 (12.4-22.8) | < 0.001 | 2.56 (1.88-3.48) | < 0.001 |
| T3 (day 7 for nutritional/day 5 for adherence) | 33.7 (28.5-38.9) | < 0.001 | 4.12 (2.95-5.76) | < 0.001 |
| Group × time interaction | 6.42 (4.15-8.69) | < 0.001 | 1.85 (1.18-2.90) | 0.008 |
Table 5 Multivariable regression analysis for predictors of postoperative recovery quality (n = 312)
| Predictors | Model 1 early recovery success (flatus < 48 hours) | Model 2 functional status at discharge (KPS) | ||||
| Adjusted OR (95%CI) | χ2 | P value | Adjusted β (95%CI) | t value | P value | |
| Watson-FTS intervention (ref: Routine) | 3.62 (2.18-6.01) | 24.15 | < 0.001 | 6.24 (4.85-7.63) | 8.82 | < 0.001 |
| Age (per year) | 0.97 (0.94-0.99) | 5.02 | 0.025 | -0.08 (-0.16 to 0.01) | -2.14 | 0.033 |
| BMI (kg/m2) | 1.04 (0.96-1.13) | 0.88 | 0.348 | 0.12 (-0.15 to 0.39) | 0.86 | 0.391 |
| Laparoscopic approach (ref: Open) | 2.45 (1.34-4.48) | 8.24 | 0.004 | 2.85 (1.12-4.58) | 3.24 | 0.001 |
| ASA class III (ref: I-II) | 0.78 (0.45-1.35) | 0.76 | 0.383 | -1.45 (-3.12 to 0.22) | -1.71 | 0.088 |
| TNM stage III (ref: I-II) | 0.82 (0.51-1.32) | 0.64 | 0.424 | -3.12 (-5.45 to 0.79) | -2.63 | 0.009 |
| Permanent stoma (ref: Temporary) | 0.88 (0.54-1.43) | 0.28 | 0.597 | -2.05 (-3.82 to 0.28) | -2.28 | 0.023 |
Table 6 Subgroup analysis of the effect of Watson-fast track surgery on time to first flatus
| Subgroup | n (Int/Con) | Adjusted beta (95%CI) | P value | P for interaction |
| Overall matched cohort | 125/125 | -15.2 (-18.4 to -12.0) | < 0.001 | Reference |
| Age (years) | 0.784 | |||
| < 65 | 74/76 | -15.4 (-18.9 to -11.9) | < 0.001 | |
| ≥ 65 | 51/49 | -14.8 (-19.2 to -10.4) | < 0.001 | |
| Surgical approach | 0.412 | |||
| Laparoscopic | 95/94 | -15.6 (-19.1 to -12.1) | < 0.001 | |
| Open | 30/31 | -13.9 (-18.2 to -9.6) | < 0.001 | |
| Stoma type | 0.521 | |||
| Permanent | 50/49 | -16.2 (-19.8 to -12.6) | < 0.001 | |
| Temporary | 75/76 | -14.5 (-18.1 to -10.9) | < 0.001 |
Table 7 Interrupted time-series analysis (segmented linear regression) evaluating the impact of the Watson-fast track surgery intervention on time to first flatus
| Parameter | Estimate (hours) | SE | 95%CI | t | P value |
| Baseline intercept (estimated time at Q1 2019) | 68.52 | 1.84 | 64.91-72.13 | 37.24 | < 0.001 |
| Preintervention trend (change per quarter before Jan 2022) | -0.15 | 0.14 | -0.42 to 0.12 | -1.07 | 0.312 |
| Level change (intervention effect) (immediate drop at Q1 2022) | -13.84 | 1.88 | -17.52 to -10.16 | -7.36 | < 0.001 |
| Postintervention trend modification (change in slope after intervention) | -0.05 | 0.1 | -0.24 to 0.14 | -0.5 | 0.62 |
- Citation: Jiang D, Shang FJ, Yu W. Association of Watson-based humanistic fast track surgery with stoma colorectal cancer recovery: A propensity matched study. World J Gastrointest Surg 2026; 18(7): 120222
- URL: https://www.wjgnet.com/1948-9366/full/v18/i7/120222.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i7.120222